T he adaptive immune system provides protection against a broad and diverse array of potential pathogens by activating an Ag-specific response tailored against the invading pathogen. In response to infection with each specific pathogen, the immune response is intricately regulated, allowing for fine-tuning of the pathogen-specific response that balances efficient pathogen eradication with minimal collateral damage to host tissues. Cytokines produced by APCs play important roles in fine-tuning the differentiation program of pathogen-specific T cells (1) . For example, during Listeria monocytogenes (Lm) 3 infection, the cytokines IL-12 and type-I IFNs each can prime naive CD4 T cells to differentiate into IFN-␥-producing Th1 cells, while the absence of both of these cytokines permits Th17 CD4 T cell differentiation provided that IL-6 and TGF-␤ are present (2, 3) . Interestingly, while the presence and/or absence of specific cytokines readily alters the differentiation program for Ag-specific CD4 T cells induced in response to Listeria infection, Ag-specific CD8 T cells maintain IFN-␥ production even under conditions where IFN-␥ production is repressed in CD4 T cells.
Recently, however, additional plasticity in the differentiation program for pathogen-specific CD8 T cells has been demonstrated. The T-box transcription factors T-bet and Eomes were shown to limit CD8 T cell plasticity in a collaborative manner, because in their absence, infection with LCMV induced the development of virus-specific CD8 T cells that produced IL-17 and had impaired IFN-␥ production and cytotoxicity (4) . These studies illuminate CD8 T cell intrinsic pathways that actively suppress IL-17 production to promote an IFN-␥-producing cytotoxic effector program. Additionally, CD8 T cells that produce IL-17 have been observed in situ in humans with psoriasis (5) and multiple sclerosis (6) , and in animal models of these and other disorders (7, 8) , as well as in healthy adults (9) , but the external signals that fostered the development of these IL-17-producing CD8 T cells are incompletely understood. In vitro, IL-21, a cytokine produced by Th17 and T follicular helper cells, can prime naive CD8 T cells to repress production of IFN-␥ while maintaining cytotoxicity (10) , and CD8 T cells cultured in cytokine conditions that allow naive CD4 T cells to differentiate into Th17 effectors, e.g., IL-6 plus TGF-␤, can produce substantial amounts of IL-17 and repress IFN-␥ production (11, 12) . Additionally, IL-23 or IL-23 plus IL-1 promote IL-17 production by total CD8 T cells in vitro (7, 13) . In this study, we describe the cell extrinsic factors regulating the differentiation of Ag-specific CD8 T cells into an IL-17/IFN-␥-dual-producing population and demonstrate how the balance of cell intrinsic factors, such as T-bet, Eomes, and ROR␥t, is altered to achieve this shift in function.
Materials and Methods

Mice
C57BL/6 mice, IL12R␤2-deficient and IL-12/23p40-deficient mice backcrossed 10 or more times to B6 were obtained from The Jackson Laboratory and bred in house. P14 TCR-transgenic (Tg) mice specific for the LCMV epitope GP 33-41 and congenic for Thy1.1 and type-I IFN receptor-deficient (IFNAR Ϫ/Ϫ ) mice were each provided by Dr. Murali-Krishna Kaja (University of Washington, Seattle, WA).
and IFNAR Ϫ/Ϫ ϫ IL12/23p40 Ϫ/Ϫ mice were generated by intercrossing. All mice were housed in a specific pathogen-free facility at the University of Washington. All experiments were performed under Institutional Animal Care and Use Committee approved protocols.
Listeria monocytogenes
For infection, 10 6 colony forming units (CFU) of the previously described Lm-OVA⌬actA strain (2, 14) was grown to early log phase (OD 600 0.1) in brain heart infusion medium (BD Biosciences) at 37°C, washed, and diluted in 200 l final volume and injected i.v.
Reagents, in vitro cultures, and cell staining
For in vivo depletion, 1.0 mg of purified anti-mouse IFN-␥ (clone XMG1.2) or IgG1 isotype control (Bio-X-Cell) was injected i.p. into mice 1 day before infection. The peptides OVA 257-264 : SIINFEKL and GP 33-41 : KAVYNFATC were each purchased from United Biochemical Research. To assess endogenous CD8 T cell responses to Lm-OVA⌬actA, splenocytes were harvested on day 7 and stimulated with SIINFEKL peptide (1 M) for 4.5 h in the presence of Brefeldin A for intracellular cytokine staining or for 72 h for assessment of culture supernatants as described (2) . For in vitro polarization cultures, IL12/23p40-deficient APCs (CD4 Ϫ CD8 Ϫ NK1.1 Ϫ CD44 low ) and naive (CD62L high CD44 low ) T cells from P14 Tg mice were purified on a FACS Aria. In brief, 2.5 ϫ 10 5 T cells and 7.5 ϫ 10 5 APCs were plated into 96-well round-bottom plates and stimulated with the P14 GP 33-41 peptide (300 ng/ml) in Iscove's modified Dulbecco's medium supplemented with 10% FBS (v/v), penicillin, streptomycin, gentamicin, and 50 nM 2-ME. Culture conditions, as indicated, included 10 ng/ml rIL-23 (eBioscience), 20 ng/ml rIL-6 (PeproTech), 10 ng/ml rIL-12/23p40 homodimer, 5 ng/ml rhTGF-␤1, 5 ng/ml rIL-12, all from R&D Systems; 10 g/ml anti-mouse/human TGF-␤1 (clone 1D11.16.8) and 10 g/ml anti-mouse IL-6R (clone 15A7), both from Bio-X-Cell. Cells were split on day 2 in fresh complete Iscove's modified Dulbecco's medium plus cytokines. Intracellular cytokine staining was performed after 5 days in culture by stimulating cells with phorbol 12-myristate 13-acetate (5 ng/ml) and ionomycin (0.7 M) for a total of 4.5 h in the presence of Brefeldin A (Golgi Plug, BD Biosciences). Abs for flow cytometry were purchased from either BD Pharmingen or eBioscience, except for anti-human granzyme B-PE that was purchased from Caltag Laboratories. IL-17 and IFN-␥ concentration within the harvested supernatants were analyzed using Luminex Beadlyte Mouse MultiCytokine Flex Kit (Upstate Biotechnology) on the Bio-Plex System (Bio-Rad). Alternatively, cultured CD8 T cells (CD8 ϩ Thy1.1 ϩ ) were purified on the FACS Aria, stimulated with PMA/ionomycin for 4.5 h, and total cellular RNA was extracted (Qiagen). SuperScript II RNase H Reverse Transcriptase (Invitrogen) was used to create cDNA and transcript abundance was analyzed by RT-PCR using TaqMan probes (Applied Biosystems) and the following primer sets:
Statistics
Differences in supernatant cytokine concentrations, percentage cytokine producing cells, and relative transcript levels were evaluated by Student's unpaired t test (Graph Pad, Prism Software).
Results
IFN-␥/IL-17 dual-producing CD8 T cells emerge in response to Lm in the absence of type-I IFN and IL-12 signaling
We previously reported that IL-12 and type-I IFNs collaborate to prime the differentiation of Ag-specific IFN-␥-producing Th1 CD4 T cells after Lm-OVA⌬actA infection (3) and that this Th1 response was abolished in IFNAR ϫ IL12/23p40 double-knockout (DKO) mice. Despite this defect, these mice mounted a robust, protective IFN-␥-producing CD8 T cell response comparable to that of wild-type (WT) mice. Because the IL-12p40 subunit is also shared by IL-23, we sought to explore further the Ag-specific T cell response after Lm infection using IL-12 receptor ␤2-deficient (IL12R␤2 knockout (KO)) mice, which have a more specific defect. Unexpectedly, we found that while the capacity of CD8 T cells from IFNAR ϫ IL12R␤2 DKO mice to produce IFN-␥ after in vitro Ag restimulation was fully maintained, these cells also secreted substantial amounts of IL-17 (Fig. 1A) . Consistent with this observation, intracellular cytokine staining revealed a modest, but consistently reproducible population of IFN-␥/IL-17 dual-producing CD8 T cells in addition to cells producing only IFN-␥ in the IFNAR ϫ IL12R␤2 DKO mice (Fig. 1, B and C) . The IFNAR ϫ IL12/23p40 DKO mice had ϳ3-fold fewer ⌱FN-␥/IL-17 dual-producing CD8 T cells than the IFNAR ϫ IL12R␤2 DKO mice (0.04% vs 0.12%). No ⌱FN-␥/IL-17 dual-producing CD8 T cells were detected in the IFNAR KO and IL-12R␤2 KO mice using intracellular staining (Fig. 1, B and C) , but low amounts of IL-17 were detected in culture supernatants (Fig. 1A) . By contrast, IL-17 production by CD8 T cells from IL-12/23p40 KO and WT mice was not detected by either method. These findings indicate that IL-23 and/or p40 homodimers (15) support the generation of Ag-specific, IFN-␥/IL-17 dual-producing CD8 T cells when both type-I IFN and IL-12 signals are absent, and that these specific cytokines play important roles in regulating IL-17 production by CD8 T cells.
IFN-␥ also inhibits the development of IL-17-producing Lm-specific CD8 T cells
During Lm infection, type-I IFNs and IL-12 synergize to prime the production of IFN-␥ by NK cells (3). IFN-␥, in turn, antagonizes the development of CD4 Th17 cells both in vitro and in vivo (3, 16 -18) . To determine the contribution of IFN-␥ to the development of Ag-specific IL-17-producing CD8 T cells that developed in the absence of type-I IFN and IL-12 signaling, we administered IFN-␥ neutralizing Ab or IgG1 isotype control Ab 1 day before Lm infection to WT and IFNAR-deficient mice.
Administration of anti-IFN-␥ to IFNAR KO mice resulted in a 5-fold increase compared with the isotype control in Ag-specific IL-17 production (2.4 ng/ml vs 0.5 ng/ml) by CD8 T cells (Fig. 2A) . This increase did not come at the expense of Ag-specific IFN-␥ production, which was also increased, but rather paralleled the emergence of an IFN-␥/IL-17 dual-producing CD8 T cell population (Fig.  2, B and C) ; however, this dual-producing population was less robust than in the IFNAR ϫ IL12R␤2 DKO mice (Fig. 1, B and C) . These results, with those shown in Fig. 1 , indicate that type-I IFNs, IL-12, and IFN-␥ together inhibit the development of IL-17-producing CD8 T cells during Lm infection, and suggest that the increased IL-17 production observed in IFNAR ϫ IL12R␤2 DKO mice may be due in part to reduced innate immune production of IFN-␥.
IL-23 enables the development of Ag-specific IFN-␥/IL-17 dual-producing CD8 T cells in vitro
To more precisely evaluate the specific cytokine signals required for the generation of IFN-␥/IL-17 dual-producing CD8 T cells, we isolated naive CD8 and CD4 T cells and stimulated them in vitro with antigenic-peptide presented by APCs from IL-12/23p40 KO mice. These APCs allow the effects of IL-12 and IL-23 on IL-17 and IFN-␥ production by T cells to be more precisely addressed.
In the absence of added cytokines, nearly all naive CD8 T cells differentiated into effectors that produced IFN-␥ and none produced detectable IL-17 (Fig. 3) . When IL-23 alone was added, a small but distinct population of IFN-␥/IL-17 dual-producing CD8 T cells was consistently observed. IL-6 and TGF-␤ dampened IFN-␥ production and induced substantial numbers of IL-17-producing and smaller numbers of IFN-␥/IL-17 dual-producing cells; (Fig. 3) . These findings indicate that in the absence of IL-12, IL-23 supports the differentiation of a fraction of naive CD8 T cells into effectors that produce both IFN-␥ and IL-17 in vitro. This effect was specific to the IL-23 p40/p19 heterodimer, because like IL-12, p40 homodimer induced only IFN-␥-producing cells (Fig. 4A) . Moreover, increasing the concentration of IL-23 10-fold augmented the percentage of IL-17-producing cells, while a similar increase in p40 homodimer did not (Fig. 4B) .
IL-23 induces IFN-␥/IL-17 dual-producing CD8 T cells in concert with endogenous IL-6 and TGF-␤
The ability of exogenous IL-23 to support the generation of IFN-␥/IL-17 dual-producing CD8 T cells in the absence of IL-12 was surprising. To determine whether IL-23 alone was sufficient or if it was acting in concert with IL-6 and TGF-␤ produced by the cultured cells, we added blocking Abs to the IL-6R and TGF-␤. Addition of these Abs greatly reduced the numbers of IFN-␥/IL-17 dual-producing CD8 T cells in cells cultured in the presence of exogenous IL-23 or in Tc17 (IL-6, TGF-␤, IL-23, anti-IL-4, and anti-IFN-␥) conditions (Fig. 4A) . These findings indicate that IL-23 is not sufficient to induce IL-17-producing CD8 T cells, but, in the absence of IL-12, can do so in concert with the amounts of IL-6 and TGF-␤ present in our cultures.
The induction by exogenous IL-23 of IFN-␥/IL-17 dual-producing CD8 T cells, suggested that these conditions were also sufficient to induce IL-23 receptor expression on these cells. To address this prediction, we assessed expression of mRNA encoding the two chains of the IL-23 receptor. Resting naive CD8 T cells did not express these receptor chains (Fig. 5) . IL-12R␤1 mRNA was induced when cells were activated under all conditions evaluated. In contrast, IL-23R expression was not induced by stimulation with Ag alone, but was markedly up-regulated within 48 h of activation in the presence of exogenous IL-23 or in Tc17 conditions.
IL-23 and IL-6 plus TGF-␤ independently and synergistically induce Rorc and Il17a and dampen Eomes expression
T cell effector differentiation is controlled by transcription factors. The transcription factors T-bet and Eomes collaborate to sustain IFN-␥ production and cytotoxic function and to repress IL-17 production by CD8 T cells (4, 19, 20) . Both ROR-␥t and ROR-␣ influence the development of CD4 T cells into Th17 cells (21, 22) , but their involvement in IL-17 expression by CD8 T cells is less well understood. To explore the role of these transcriptional regulators in the development of IFN-␥/IL-17 dual-producing CD8 T cells, we evaluated their expression under the conditions described above. Expression of Rorc (ROR-␥t), Rora (ROR-␣), Il17a, and Il21 increased modestly when naive CD8 T cells were activated in the presence of IL-23 alone, more strongly in the presence of IL-6 plus TGF-␤, and maximally in Tc17 conditions. Reciprocally, IL-23 alone did not substantially alter Eomes or Ifng expression, whereas both were repressed by IL-6 plus TGF-␤ and in Tc17 conditions. IL-12 blocked this induction of Rorc and Il17a and up-regulated Ifng expression, whereas expression of Rora (ROR-␣) and Il21 were not affected (Fig. 6, A and B) . Levels of 
IL-6 and TGF-␤ but not IL-23 diminish the expression of the cytolytic molecules granzyme B and perforin
A key function of effector CD8 T cells resides in their ability to produce granzyme B and perforin to exert cytotoxic activity on infected cells, the expression of which is up-regulated by T-bet and Eomes (4). Production of IFN-␥ and cytotoxic activity in CD8 T cells is not always coordinate, as IL-21 can repress the production of IFN-␥ while maintaining cytotoxicity (10) . When we assessed these mediators of cytotoxicity, we found that IL-12 enhanced, TGF-␤ plus IL-6 and Tc17 conditions inhibited, and exogenous IL-23 alone had no effect on granzyme B abundance (Fig. 7A) and granzyme B and perforin mRNA expression (Fig. 7B) . Together, these results indicate that IL-6 and TGF-␤ are sufficient to dramatically reprogram CD8 T cell function by inducing robust IL-17 production and inhibiting their canonical functions of cytotoxicity and IFN-␥ production, whereas IL-23 preserved these canonical functions while inducing low-level IL-17 production.
Discussion
Taken together, these findings demonstrate that Ag-specific CD8 effector T cells that produce both IL-17 and IFN-␥ can arise in response to infection in vivo. These findings corroborate those of Hamada et al. (12) , who identified the emergence of an IFN-␥/ IL-17 dual-producing CD8 T cell population in the lungs of influenza-infected mice. During Lm infection, IL-17A produced by ␥␦ T cells helps to promote bacterial clearance and the formation of organized granulomas within the liver (23) . Our studies indicate that in the absence of inhibitory signals, IL-17-producing adaptive immune cells can also be generated during Lm infection. We show in this study that the emergence of these IFN-␥/IL-17 dual-producing CD8 T cells is inhibited by IL-12, type-I IFNs and IFN-␥, which instead promote the canonical cytotoxic, IFN-␥-producing CD8 T cell phenotype. Furthermore, we also show that emergence of these IL-17-producing CD8 T cells in vivo was also dependent on IL-23, because it was markedly reduced in IFNAR ϫ 40 DKO mice, which lack IL-23, IL-12, and type-I IFN signaling, while IL-17-producing CD8 T cells were most pronounced in IFNAR ϫ IL-12R␤2 DKO mice, in which IL-23 signaling is retained. When we tested the ability of p40 homodimers to induce IL-17 production in vitro, we found that they were unable to do so, indicating that IL-23 and not p40 homodimers was required.
IL-6 and TGF-␤ have been clearly implicated in the induction of CD4 Th17 cells, while IL-23 is believed to be more important in the terminal differentiation and survival of Th17 cells (24, 25) . We found that IL-6 and TGF-␤ were also essential for IL-17 production by CD8 T cells, and previous reports have demonstrated that IL-23 can stimulate the production of IL-17 by memory CD8 T cells (7, 8) . However, to our knowledge, this is the first demonstration that IL-23, when type I promoting cytokines are blocked, is sufficient to promote the development of naive CD8 T cells into IFN-␥/IL-17 dual-producers. These effects of IL-23 were dependent on endogenous IL-6 and TGF-␤ and could be amplified by the further addition of exogenous IL-6 and TGF-␤. Weaver and colleagues (26) showed that IL-23 could support IL-17 production by CD4 T cells in the absence of exogenous IL-6 and TGF-␤ when inhibitory signals, such as IL-12 and IFN-␥, were eliminated. Our results show that this is also true for CD8 T cells.
Our report also directly links cell-extrinsic cytokine-triggered IL-17 and IFN-␥ production with levels of cell-intrinsic lineagedefining transcription factors. The importance of T-bet and Eomes in CD8 effector function has been appreciated, and gradations of T-bet and Eomes modulate CD8 function and survival (27) (28) (29) . Our studies implicate Eomes as an important regulator of CD8 T cell cytotoxic activity, as the repression of Eomes upon the addition of IL-6 and TGF-␤ paralleled the suppression of granzyme B and perforin. Conversely, inhibition of these cytotoxic proteins and IFN-␥ correlated directly with the increased expression of ROR-␥t. In summary, our findings show that, depending on the cytokine milieu, CD8 T cells have the ability to differentiate into one of several populations: canonical CD8 effectors producing only IFN-␥, and subsets producing IFN-␥ and IL-17, or, at least in vitro, only IL-17. The diversity of populations indicates that although CD8 T cell differentiation is less plastic than for CD4 T cells, CD8 effector function is nonetheless clearly affected by the overall cytokine milieu.
